X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (297) 297
Publication (23) 23
Patent (6) 6
Dissertation (3) 3
Book / eBook (1) 1
Book Chapter (1) 1
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (136) 136
microbiology (133) 133
infectious diseases (121) 121
index medicus (97) 97
microbial sensitivity tests (71) 71
taiwan (64) 64
female (58) 58
anti-bacterial agents - pharmacology (56) 56
infectious disease (56) 56
male (55) 55
immunology (52) 52
infections (47) 47
aged (46) 46
pharmacology & pharmacy (44) 44
middle aged (43) 43
taiwan - epidemiology (43) 43
adult (35) 35
animals (34) 34
epidemiology (33) 33
bacterial infections and mycoses (30) 30
medical education (29) 29
biochemical phenomena, metabolism, and nutrition (28) 28
hospitals (28) 28
immunology and allergy (28) 28
anti-bacterial agents - therapeutic use (27) 27
bacteremia (27) 27
immunology and microbiology (27) 27
bacteria (26) 26
enterobacteriaceae (26) 26
mice (26) 26
pneumonia (26) 26
escherichia-coli (25) 25
aged, 80 and over (23) 23
antibiotics (23) 23
medicine (23) 23
prevalence (23) 23
infection (22) 22
polycyclic compounds (22) 22
research (22) 22
bacterial proteins - genetics (21) 21
beta-lactamases - genetics (21) 21
drug resistance, bacterial (21) 21
health aspects (21) 21
internal medicine (21) 21
minocycline - pharmacology (21) 21
tigecycline (21) 21
klebsiella pneumoniae - genetics (19) 19
research article (19) 19
drug synergism (18) 18
antimicrobial agents (17) 17
klebsiella infections - microbiology (17) 17
klebsiella pneumoniae - isolation & purification (17) 17
molecular sequence data (17) 17
susceptibility (17) 17
drug resistance (16) 16
klebsiella pneumoniae - drug effects (16) 16
mice, inbred balb c (16) 16
minocycline - analogs & derivatives (16) 16
bacterial pneumonia (15) 15
beta-lactamases - biosynthesis (15) 15
klebsiella pneumoniae (15) 15
medicine, general & internal (15) 15
multidisciplinary sciences (15) 15
nosocomial infections (15) 15
virulence (15) 15
carbapenems - pharmacology (14) 14
mortality (14) 14
surveillance (14) 14
vibrio vulnificus (14) 14
genes (13) 13
klebsiella (13) 13
medical research (13) 13
molecular epidemiology (13) 13
resistance (13) 13
retrospective studies (13) 13
analysis (12) 12
antimicrobial resistance (12) 12
bacteremia - microbiology (12) 12
cefotaxime (12) 12
ciprofloxacin (12) 12
escherichia coli (12) 12
klebsiella-pneumoniae (12) 12
strains (12) 12
acinetobacter baumannii - drug effects (11) 11
base sequence (11) 11
cefotaxime - pharmacology (11) 11
drug resistance, multiple, bacterial (11) 11
e coli (11) 11
genetic aspects (11) 11
identification (11) 11
klebsiella pneumoniae - enzymology (11) 11
polymerase chain reaction (11) 11
time factors (11) 11
adolescent (10) 10
amino acid sequence (10) 10
antibacterial agents (10) 10
cloning (10) 10
cross infection (10) 10
dosage and administration (10) 10
drug resistance in microorganisms (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 2010, Volume 68, Issue 2, pp. 140 - 151
Abstract To compare efficacy and safety of a tigecycline regimen with an imipenem/cilastatin regimen in hospital-acquired pneumonia patients, a phase 3,... 
Infectious Disease | Internal Medicine | Antimicrobial | Pneumonia | Ventilator/non–ventilator-associated pneumonia | Nosocomial | Glycylcycline | Ventilator/non-ventilator-associated pneumonia | INFECTIOUS DISEASES | CLINICAL-TRIAL | VENTILATOR-ASSOCIATED PNEUMONIA | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | EXPOSURE-RESPONSE ANALYSES | IMIPENEM-CILASTATIN | SKIN-STRUCTURE INFECTIONS | INTENSIVE-CARE-UNIT | COMPLICATED INTRAABDOMINAL INFECTIONS | ANTIMICROBIAL ACTIVITY | NOSOCOMIAL PNEUMONIA | Imipenem - therapeutic use | Pneumonia, Ventilator-Associated - mortality | Cilastatin - adverse effects | Minocycline - pharmacology | Humans | Minocycline - analogs & derivatives | Cross Infection - mortality | Cilastatin - pharmacokinetics | Imipenem - pharmacokinetics | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Minocycline - adverse effects | Pneumonia - mortality | Minocycline - therapeutic use | Anti-Bacterial Agents - adverse effects | Cilastatin - therapeutic use | Cilastatin - pharmacology | Pneumonia, Ventilator-Associated - drug therapy | Double-Blind Method | Hospital Mortality | Bacterial Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Imipenem - pharmacology | Pneumonia - drug therapy | Minocycline - pharmacokinetics | Drug Combinations | Imipenem - adverse effects
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 2015, Volume 48, Issue 2, pp. S173 - S173
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 2015, Volume 48, Issue 2, pp. S87 - S87
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 2015, Volume 48, Issue 2, pp. S108 - S108
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, p. e69428
Objectives: The global spread and increasing incidence of carbapenem non-susceptible Klebsiella pneumoniae (CnSKP) has made its treatment difficult, increasing... 
UNITED-STATES | BACTEREMIA | MULTIDISCIPLINARY SCIENCES | ST11 | SEQUENCE TYPE 258 | MOLECULAR EPIDEMIOLOGY | BETA-LACTAMASES | K. PNEUMONIAE | RESISTANT KLEBSIELLA | OUTBREAK | FIELD GEL-ELECTROPHORESIS | Cefazolin - pharmacology | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Bacterial Proteins - genetics | Ciprofloxacin - pharmacology | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Carbapenems - pharmacology | beta-Lactamases - genetics | Klebsiella pneumoniae - enzymology | Taiwan | Bacterial Proteins - metabolism | Cefotaxime - pharmacology | Anti-Bacterial Agents - pharmacology | beta-Lactamases - metabolism | Klebsiella | Complications and side effects | Drug resistance in microorganisms | Distribution | Physiological aspects | Dosage and administration | Genetic aspects | Research | Carbapenems | Epidemics | Intensive care | Cefotaxime | Colistin | Laboratories | Genes | Carbapenemase | Epidemiology | Genetic relationship | Pulsed-field gel electrophoresis | CRE bacteria | Emergence | Armed forces | Urinary tract infections | Urogenital system | Ceftazidime | Medical research | Enzymes | Gel electrophoresis | Cloning | Antimicrobial agents | Permeability | Cefoxitin | Disease control | Urinary tract diseases | Medicine | Infectious diseases | Hospitals | Cefazolin | Surveillance | Antibiotics | Tigecycline | Ciprofloxacin
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 1, pp. 166 - 171
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 12/2017, Volume 50, Issue 6, p. 931
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.jmii.2016.12.008 To... 
Klebsiella infections | Medical research | Colistin | Drug interactions | Medicine, Experimental | Dosage and administration | Drug therapy, Combination | Research | Comparative analysis | Drug therapy | Methods | Fosfomycin
Journal Article
Journal of Microbiology, Immunology and Infection, ISSN 1684-1182, 12/2017, Volume 50, Issue 6, pp. 931 - 939
Purpose: To investigate the synergistic and bactericidal effects of antimicrobial combinations of any two of colistin, fosfomycin and tigecycline against the... 
Journal Article
Journal Article
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2012, Volume 40, Issue 1, pp. S37 - S43
Summary In 2009, the Study for Monitoring Antimicrobial Resistance Trends (SMART) was expanded to include surveillance of Gram-negative pathogens causing... 
Infectious Disease | Asia-Pacific region | Fluoroquinolone resistance | Urinary tract infections | Extended-spectrum β-lactamase (ESBL) | SMART | Carbapenems | Interpretive susceptibility criteria | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | Extended-spectrum beta-lactamase (ESBL) | INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | BACILLI | Penicillanic Acid - pharmacology | Prevalence | Prospective Studies | Ceftazidime - pharmacology | Humans | Australasia - epidemiology | Drug Resistance, Bacterial | Amikacin - pharmacology | beta-Lactamases - biosynthesis | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacteria - enzymology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Asia - epidemiology | Piperacillin - pharmacology | beta-Lactams - pharmacology | Carbapenems - pharmacology | Gram-Negative Bacteria - pathogenicity | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Penicillanic Acid - analogs & derivatives | Moxalactam | Levofloxacin | Pneumonia | Bacterial pneumonia | Disease susceptibility | Antibacterial agents | Cephalosporins | Beta lactamases | Cephaloridine | Bacteria | Cross infection | Nosocomial infections | Ciprofloxacin | Health aspects
Journal Article
Journal Article
BioMed Research International, ISSN 2314-6133, 2015, Volume 2015, pp. 1 - 5
Journal Article